CGEM Cullinan Therapeutics
- 18.880
- -2.920-13.39%
- 19.260
- +0.380+2.01%
Cullinan Therapeutics News
Cullinan Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ebeling Thomas
Cullinan Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.8%)
Cullinan Therapeutics | EFFECT: Others
Cullinan Therapeutics | 424B3: Prospectus
Cullinan Therapeutics | 8-K: Current report
Cullinan Therapeutics | 8-K: Current report
Cullinan Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ebeling Thomas
Cullinan Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Meek David D.
Cullinan Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Meek David D.
Cullinan Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Cullinan Therapeutics | ARS: Annual Report to Security Holders
Cullinan Therapeutics | DEFA14A: Others
Cullinan Therapeutics | DEF 14A: Definitive information statements
Cullinan Therapeutics | 10-Q: Quarterly report
Cullinan Therapeutics | 8-K: Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Cullinan Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Michaelson Jennifer
Cullinan Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Cullinan Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fenton Mary Kay
Cullinan Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Fenton Mary Kay
Cullinan Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
